Premium
Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response
Author(s) -
Yu Miao,
TerhorstMolawi Dorothea,
Altrichter Sabine,
Hawro Tomasz,
Chen YuDi,
Liu Bo,
Song Xiaoting,
Zhao Zuotao,
Maurer Marcus
Publication year - 2021
Publication title -
clinical and experimental allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 154
eISSN - 1365-2222
pISSN - 0954-7894
DOI - 10.1111/cea.13838
Subject(s) - omalizumab , medicine , chronic urticaria , intensive care medicine , dermatology , immunology , immunoglobulin e , antibody
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom